Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

This Biotech Has Soared 73% Since Monday

Shares of micro-cap biotech Inovio Pharmaceuticals Inc. (NYSE: INO) gained as much as 33% yesterday after the company announced "peer-reviewed" publication of results from two Phase I trials involving the company's HIV DNA vaccine.

The stock is up 73% since Monday and 107% since we recommended it to you back in early February. It ended yesterday higher by 24.6%.

The surge this week is due to several announcements the company has made. On Tuesday, we told you that the Blue Bell, Pa.-based biotech said that its universal H7N9 "Bird Flu" DNA Vaccine protected 100% of vaccinated animals in a challenge study.

This company - headed by CEO J. Joseph Kim - has an exceptional management team, promising technology and an extremely promising outlook, says Michael Robinson, our resident tech expert and the editor of the Radical Technology Profits advisory service.

To continue reading, please click here...

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK